Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Soo-Jeung Park, Young S. Hahn

Clin Mol Hepatol. 2023;29(1):65-76. Published online August 12, 2022

DOI: https://doi.org/10.3350/cmh.2022.0032

View: 5060 Download: 175 Web of Science: 8 Crossref: 9

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina

Clin Mol Hepatol. 2020;26(4):728-735. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0202

View: 6218 Download: 183 Web of Science: 27 Crossref: 26

Se Jin Im , Young Chul Sung

Clin Mol Hepatol. 2006;12(2):154-162. Published online January 1, 1970

View: 2725 Download: 47

Eui Cheol Shin

Clin Mol Hepatol. 2006;12(2):140-153. Published online January 1, 1970

View: 2359 Download: 22

Michael G. Tovey

Clin Mol Hepatol. 2002;8(2):125-131. Published online January 1, 1970

View: 4006 Download: 27

1 |

Viewed By 5348	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5297	MAFLD: How is it different from NAFLD?
Viewed By 5193	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3886	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3841	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search